Hereditary Hemorrhagic Telangiectasia (HHT) Center

The Health Resources and Services Administration (HRSA) is accepting applications for the fiscal year (FY) 2022 Hereditary Hemorrhagic Telangiectasia (HHT) Center.

The purpose of the program is to reduce morbidity and mortality associated with hereditary hemorrhagic telangiectasia by funding a

credit:


national center to:
1) expand access to and coordination of care for HHT patients; and 2) develop a de-identified, aggregate data collection registry to better understand this rare disease and treatment outcomes.
Related Programs

Maternal and Child Health Federal Consolidated Programs

Department of Health and Human Services






Obtain Full Opportunity Text:
The full announcement is located under the tab "Related Documents" at the top of this synopsis.

Additional Information of Eligibility:
Any domestic public or private entity, including an Indian tribe or tribal organization (as those terms are defined at 25 U.S.C.

5304 (formerly cited as 25 U.S.C.

450b)) is eligible to apply.

See 42 CFR § 51a.3(a)).

Domestic faith-based and community-based organizations are eligible to apply.

Full Opportunity Web Address:
https://ojjdp.ojp.gov/funding/fy2022/O-OJJDP-2022-171205

Contact:


Agency Email Description:
Contact Cristina Novoa, Ph.D. at (301)443-1463 or email cnovoa@hrsa.gov

Agency Email:


Date Posted:
2022-03-18

Application Due Date:


Archive Date:
2022-07-23


In the world of social enterprises, failure is a cringe-worthy moment nobody wants to talk about. But, social entrepreneurs can benefit from their failures.






More Federal Domestic Assistance Programs


Migrant Education_Coordination Program | Architectural and Transportation Barriers Compliance Board | Assistance to Firefighters Grant | Hawaii Sugar Disaster Program | National Wetlands Inventory |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2025 Copyright Michael Saunders